Publications

Reviews:

1: Masroor, A., Streefkerk, N., Van Grotel, M., et al., Local application of otoprotective compounds other than sodium thiosulfate to prevent cisplatin-induced hearing loss: a systematic review. Drug Delivery , 33(1), 2026. https://doi.org/10.1080/10717544.2026.2665892

2: Bracesco, L., Hendriks, D. & Artegiani, B., Fusion oncogenes in cancer: organoid models and novel therapeutic approaches. BMC Biology , 24, 135, 2026. https://doi.org/10.1186/s12915-026-02606-7

3: Streefkerk, N., Timmer, R., Larsson, AIE, et al., Prestin as a potential biomarker for cochlear injury: current evidence and future directions. European Archives of Oto-Rhino-Laryngology , 2026. https://doi.org/10.1007/s00405-026-10236-6

Articles:

1: Beamish J, de Fine Licht E, Boström P, et al.,  Socioeconomic status and longitudinal neurocognitive outcomes following childhood brain tumour diagnosis: a Swedish national population-based cohort study. Neuro Oncol. 2026 Oct 8:noag253. doi: 10.1093/neuonc/noag253. Epub ahead of print. PMID: 42848686.

2: Miguel Vieira Martins , Amir Enshaei , Yang Yang Wang , et al., EARLY RESPONSE AND GENETICS DEFINE RELAPSE RISK AFTER FRONTLINE BLINATUMOMAB IN CHILDHOOD B-ALL: A COHORT STUDY. Blood Adv., Sept 1, 2026, https://doi.org/10.1016/j.ctro.2025.101051

3: Ding, M., Maspero, M., Harrabi, S., et al., Impact of deep learning on CT-based organ-at-risk delineation for flank irradiation in pediatric renal tumors: a SIOP-RTSG radiotherapy committee study. Clinical and Translational Radiation Oncology , 56, 2026, 101051. https://doi.org/10.1016/j.ctro.2025.101051

4: Klein Lebbink, WJ, De Koning, CC, Kunstek, H., et al., Identification of a Plasma Immune Marker Panel for Early Detection of Acute Graft-versus-Host Disease in Children. Blood Immunology & Cellular Therapy , 2026, 100035. https://doi.org/10.1016/j.bict.2026.100035

5: Vieira Martins, M., de Lorenzo, P., Kotecha, RS, et al., Sustained Benefit of Blinatumomab in Infants With KMT2A-Rearranged ALL: Long-Term Outcomes, Toxicity, and Pharmacokinetics. Journal of Clinical Oncology , 2026 Jan 8:JCO2501806. https://doi.org/10.1200/JCO-25-01806

6: Hanemaaijer, ES, Müskens, KF, Kal, IJ, et al., Single-cell multiomic atlas of healthy pediatric bone marrow reveals age-dependent differences in lineage differentiation driven by stromal signaling. Nature Immunology , 27, 613–623, 2026. https://doi.org/10.1038/s41590-026-02422-9

7: Tallon-Cobos, A.C., Vazaios, K., Waranecki, P., et al., CAR T cells targeting the glycoprotein GD2 show potent antitumor efficacy in high-risk ependymoma models. Journal of Clinical Investigation , 136(2), 2026, e193332. https://doi.org/10.1172/JCI193332

8: Yurddas, D., Nievelstein, RAJ, Bison, B., et al., Hypothalamic obesity following craniopharyngioma surgery: what is the role of hypothalamic T2 signal changes in brain MRI? Neuro-Oncology Advances , 8(1), January–December 2026, vdag050. https://doi.org/10.1093/noajnl/vdag050

9: Streefkerk, N., Geller, JI, Knight, K., et al., Avoiding Cisplatin-Related Hearing Loss, Including Implementing Sodium Thiosulfate as Otoprotectant Into Daily Pediatric Clinical Practice: Proceedings Based on Evidence and Expert Opinion From the Ototoxicity Taskforce of the SIOP Supportive Care Network. Ear and Hearing , 2026 Jun 26 (Epub ahead of print), PMID: 42370844. https://doi.org/10.1097/AUD.0000000000001856

10: Park, SWS, Sundquist, F., Teles, L., et al., Fraction-dependent dose dynamics and clinical safety in high-risk neuroblastoma treated with [177Lu]Lu-DOTATATE: results from the LuDO-N trial. European Journal of Nuclear Medicine and Molecular Imaging , 2026. https://doi.org/10.1007/s00259-026-07984-2

11: Beamish, J., Damiano, RM, Drijver, J., et al., The relationship between psychosocial risk and neurocognitive functioning early after childhood central nervous system tumor diagnosis. Journal of Neuropsychology , 2026, 1–18. https://doi.org/10.1111/jnp.70060

12: Teles L, Tolboom N, Poot AJ, et al., Radioligand therapy for pediatric patients with solid tumors. Br J Radiol. 2026 Jul 7:tqag161. doi: 10.1093/bjr/tqag161. Epub ahead of print. PMID: 42412529.

13: Vieira Martins M, de Lorenzo P, Kotecha RS, et al., Immunoglobulin Depletion and Recovery Following Blinatumomab in Infants With KMT2A-Rearranged ALL. Pediatric Blood Cancer. 2026 Jul 24:e70547. doi: 10.1002/1545-5017.70547 . Epub ahead of print. PMID: 42496646.

Reviews:

1: Nienke Streefkerk, Amirhossein Masroor, James I. Geller et al. , Local application of sodium thiosulfate as an otoprotectant for cisplatin-exposed patients – A narrative literature review to explore the potential benefit for children with cancer, EJC Pediatric Oncology, Volume 5, 2025, 100211, https://doi.org/10.1016/j.ejcped.2024.100211 ( https://www.sciencedirect.com/science/article/pii/S2772610X24000710)

2: Jessica Beamish, Josephine Drijver, Marita Partanen,
Cognitive and adaptive functioning outcomes after cancer diagnosis in early childhood: A systematic review, EJC Pediatric Oncology,
Volume 5, 2025, 100237, https://doi.org/10.1016/j.ejcped.2025.100237. ( https://www.sciencedirect.com/science/article/pii/S2772610X2500025X )

Articles:

1: Mianyong Ding, Matteo Maspero, Annemieke S. Littooij, et al. , Deep learning-based auto-contouring of organs/structures-at-risk for pediatric upper abdominal radiotherapy, Radiotherapy and Oncology, 2025, 110914, https://doi.org/10.1016/j.radonc.2025.110914. https://www.sciencedirect.com/science/article/pii/S0167814025002099
 

2: Miguel Vieira Martins, Anna Sofie Buhl Rasmussen, Jesper Heldrup